The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drugs for Malaria-Global Market Insights and Sales Trends 2025
Synopsis
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
The global Drugs for Malaria market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Malaria in various end use industries. The expanding demands from the Prevention, Treatment and Others,, are propelling Drugs for Malaria market. Aryl Aminoalcohol Compounds, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antifolate Compounds segment is estimated at % CAGR for the next seven-year period.
In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Malaria market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Malaria market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Malaria sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Malaria covered in this report include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc.
The global Drugs for Malaria market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Global Drugs for Malaria market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Malaria market, Segment by Type:
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Global Drugs for Malaria market, by Application
Prevention
Treatment
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drugs for Malaria companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
The global Drugs for Malaria market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Malaria in various end use industries. The expanding demands from the Prevention, Treatment and Others,, are propelling Drugs for Malaria market. Aryl Aminoalcohol Compounds, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antifolate Compounds segment is estimated at % CAGR for the next seven-year period.
In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Malaria market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Malaria market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Malaria sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Malaria covered in this report include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc.
The global Drugs for Malaria market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Global Drugs for Malaria market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Malaria market, Segment by Type:
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Global Drugs for Malaria market, by Application
Prevention
Treatment
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drugs for Malaria companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drugs for Malaria
1.1 Drugs for Malaria Market Overview
1.1.1 Drugs for Malaria Product Scope
1.1.2 Drugs for Malaria Market Status and Outlook
1.2 Global Drugs for Malaria Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drugs for Malaria Market Size by Region (2018-2029)
1.4 Global Drugs for Malaria Historic Market Size by Region (2018-2023)
1.5 Global Drugs for Malaria Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drugs for Malaria Market Size (2018-2029)
1.6.1 North America Drugs for Malaria Market Size (2018-2029)
1.6.2 Europe Drugs for Malaria Market Size (2018-2029)
1.6.3 Asia-Pacific Drugs for Malaria Market Size (2018-2029)
1.6.4 Latin America Drugs for Malaria Market Size (2018-2029)
1.6.5 Middle East & Africa Drugs for Malaria Market Size (2018-2029)
2 Drugs for Malaria Market by Type
2.1 Introduction
2.1.1 Aryl Aminoalcohol Compounds
2.1.2 Antifolate Compounds
2.1.3 Artemisinin Compounds
2.2 Global Drugs for Malaria Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drugs for Malaria Historic Market Size by Type (2018-2023)
2.2.2 Global Drugs for Malaria Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drugs for Malaria Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drugs for Malaria Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drugs for Malaria Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drugs for Malaria Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drugs for Malaria Revenue Breakdown by Type (2018-2029)
3 Drugs for Malaria Market Overview by Application
3.1 Introduction
3.1.1 Prevention
3.1.2 Treatment
3.1.3 Others
3.2 Global Drugs for Malaria Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drugs for Malaria Historic Market Size by Application (2018-2023)
3.2.2 Global Drugs for Malaria Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drugs for Malaria Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drugs for Malaria Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drugs for Malaria Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drugs for Malaria Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drugs for Malaria Revenue Breakdown by Application (2018-2029)
4 Drugs for Malaria Competition Analysis by Players
4.1 Global Drugs for Malaria Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2022)
4.3 Date of Key Players Enter into Drugs for Malaria Market
4.4 Global Top Players Drugs for Malaria Headquarters and Area Served
4.5 Key Players Drugs for Malaria Product Solution and Service
4.6 Competitive Status
4.6.1 Drugs for Malaria Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cipla
5.1.1 Cipla Profile
5.1.2 Cipla Main Business
5.1.3 Cipla Drugs for Malaria Products, Services and Solutions
5.1.4 Cipla Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.1.5 Cipla Recent Developments
5.2 Guilin Pharmaceutical
5.2.1 Guilin Pharmaceutical Profile
5.2.2 Guilin Pharmaceutical Main Business
5.2.3 Guilin Pharmaceutical Drugs for Malaria Products, Services and Solutions
5.2.4 Guilin Pharmaceutical Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.2.5 Guilin Pharmaceutical Recent Developments
5.3 IPCA Laboratories
5.3.1 IPCA Laboratories Profile
5.3.2 IPCA Laboratories Main Business
5.3.3 IPCA Laboratories Drugs for Malaria Products, Services and Solutions
5.3.4 IPCA Laboratories Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Drugs for Malaria Products, Services and Solutions
5.4.4 GlaxoSmithKline Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Mylan Labs
5.5.1 Mylan Labs Profile
5.5.2 Mylan Labs Main Business
5.5.3 Mylan Labs Drugs for Malaria Products, Services and Solutions
5.5.4 Mylan Labs Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.5.5 Mylan Labs Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Drugs for Malaria Products, Services and Solutions
5.6.4 Roche Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Drugs for Malaria Products, Services and Solutions
5.7.4 Novartis Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Sanofi Aventis
5.8.1 Sanofi Aventis Profile
5.8.2 Sanofi Aventis Main Business
5.8.3 Sanofi Aventis Drugs for Malaria Products, Services and Solutions
5.8.4 Sanofi Aventis Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Aventis Recent Developments
5.9 Ajanta Pharma
5.9.1 Ajanta Pharma Profile
5.9.2 Ajanta Pharma Main Business
5.9.3 Ajanta Pharma Drugs for Malaria Products, Services and Solutions
5.9.4 Ajanta Pharma Drugs for Malaria Revenue (US$ Million) & (2018-2023)
5.9.5 Ajanta Pharma Recent Developments
6 North America
6.1 North America Drugs for Malaria Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drugs for Malaria Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Malaria Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drugs for Malaria Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Malaria Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drugs for Malaria Market Dynamics
11.1 Drugs for Malaria Industry Trends
11.2 Drugs for Malaria Market Drivers
11.3 Drugs for Malaria Market Challenges
11.4 Drugs for Malaria Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
